BioMark Diagnostics Underscores Commitment to Rare DiseaseResearch on Rare Disease Day 2025
BioMark Diagnostics Underscores Commitment to Rare Disease Research on Rare Disease Day 2025 BioMark is pioneering liquid biopsy solutions for challenging conditions and championing equity in diagnosis Vancouver, British Columbia – (February 28, 2025) – BioMark Diagnostics Inc. (“BioMark”) (CSE: BUX) (FSE: 20B) (OTCMKTS: BMKDF), a leading developer of liquid biopsy tests for early cancer […]
Form 7 Monthly Progress Report March 2025
Form 7 Monthly Progress Report February 2025 Name of Listed Issuer: Trading Symbol: Number of Outstanding Listed Securities: Date: BioMark Diagnostics Inc. (the “Issuer”) BUX 90,886,229 March 4, 2025 This Monthly Progress Report must be posted before the opening of trading on the fifth trading day of each month. This report is not intended to […]
From Black Plastics to Biomarkers How Environmental Causes of Cancer Can Be Prevented
From Black Plastics to Biomarkers How Environmental Causes of Cancer Can Be Prevented Seemingly harmless environmental factors in our homes can contribute to cancer risk. What you can do about it? Learn about the dangers of toxic chemicals like flame retardants and PFASs found in common household items such as plastic utensils and non-stick pans. […]
Form 7 Monthly Progress Report February 2025
Form 7 Monthly Progress Report January 2025 Name of Listed Issuer: Trading Symbol: Number of Outstanding Listed Securities: Date: BioMark Diagnostics Inc. (the “Issuer”) BUX 90,886,229 February 3, 2025 This Monthly Progress Report must be posted before the opening of trading on the fifth trading day of each month. This report is not intended to […]
Cancer is Rising Among Women: Early Detection of Lung Cancer
Cancer is Rising Among Young Women: Early Detection of Lung Cancer Lung cancer rates are rising among younger women, making early detection more critical than ever. There is an alarming trend of increased diagnoses in women and it emphasizes the importance of early detection for successful treatment. Innovative technologies, like Biomark Diagnostics’ liquid biopsy, can […]
Cancer Prevention: 5 Actionable Steps
Cancer Prevention: 5 Actionable Steps Take control of your health and reduce your cancer risk through simple lifestyle changes! We present five actionable steps for cancer prevention, including quitting inhalants, limiting alcohol and sugary drinks, increasing physical activity, and making healthy food choices. We also discuss the importance of early cancer detection through regular checkups […]
Form 7 Monthly Progress Report January 2025
Form 7 Monthly Progress Report December 2024 Name of Listed Issuer: Trading Symbol: Number of Outstanding Listed Securities: Date: BioMark Diagnostics Inc. (the “Issuer”) BUX 90,886,229 January 3, 2025 This Monthly Progress Report must be posted before the opening of trading on the fifth trading day of each month. This report is not intended to […]
BioMark’s Liquid Biopsy Platform Takes A Major Step Forward in Breast Cancer Diagnosiswith AI-powered ER Status Prediction
BioMark’s Liquid Biopsy Platform Takes A Major Step Forward in Breast Cancer Diagnosis with AI-powered ER Status Prediction BioMark Expands Its Liquid Biopsy Platform Receptor Status for Breast Cancer Vancouver, British Columbia – (December 10, 2024) – BioMark Diagnostics Inc. (“BioMark”) (CSE: BUX) (FSE: 20B) (OTCMKTS: BMKDF), a leader in liquid biopsy tests for early […]
Form 7 Monthly Progress Report December 2024
Form 7 Monthly Progress Report December 2024 Name of Listed Issuer: Trading Symbol: Number of Outstanding Listed Securities: Date: BioMark Diagnostics Inc. (the “Issuer”) BUX 90,886,229 December 2th, 2024 This Monthly Progress Report must be posted before the opening of trading on the fifth trading day of each month. This report is not intended to […]
BioMark Expands its Liquid Biopsy Platform with two Groundbreaking Publications in Breast Cancer Detection
BioMark Expands its Liquid Biopsy Platform with two Groundbreaking Publications in Breast Cancer Detection BioMark Strengthens Liquid Biopsy Platform for Breast Cancer Detection Vancouver, British Columbia – (November 5, 2024) – BioMark Diagnostics Inc. (“BioMark”) (CSE: BUX) (FSE: 20B) (OTCMKTS: BMKDF), a leading developer of liquid biopsy tests for early cancer detection, today announced significant […]
